4//SEC Filing
McGuire Jonathan Will 4
Accession 0001209191-20-059394
CIK 0001716621other
Filed
Nov 18, 7:00 PM ET
Accepted
Nov 19, 4:33 PM ET
Size
5.7 KB
Accession
0001209191-20-059394
Insider Transaction Report
Form 4
McGuire Jonathan Will
DirectorChief Executive Officer
Transactions
- Award
Common Stock
2020-11-17+104,254→ 110,054 total
Footnotes (2)
- [F1]The reported shares were issued as a restricted stock award ("RSA"). 50% of the shares underlying the RSA shall vest and become non-forfeitable as follows: 1/3 of the number of shares will vest on November 20, 2021, and 1/6th of the number of shares will vest on each May 20 and November 20 thereafter, such that 50% of the RSA will be fully vested on November 20, 2023; provided, however, that if a vesting date would otherwise fall on a day when the national stock exchange upon which the shares are listed is not open for trading, vesting will occur on the first trading day thereafter. The remaining 50% of the shares underlying the RSA shall vest and become non-forfeitable upon certain performance milestones being met by November 20, 2021. Vesting in all instances is subject to the reporting person's continuous status as a Service Provider (as defined in the 2018 Equity Incentive Plan) through each vesting date.
- [F2]On November 16, 2020, the common stock of the company reverse-split 25-for-1, resulting in the reporting persons ownership being reduced by 139,200.
Documents
Issuer
Ra Medical Systems, Inc.
CIK 0001716621
Entity typeother
Related Parties
1- filerCIK 0001345539
Filing Metadata
- Form type
- 4
- Filed
- Nov 18, 7:00 PM ET
- Accepted
- Nov 19, 4:33 PM ET
- Size
- 5.7 KB